• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Prevent Blindness designates April as Women’s Eye Health and Safety Month

Article

Women are at higher risk of eye disease than men.

Image Credit: © Halfpoint - stock.adobe.com

Women have a higher prevalence of many of the major vision problems including: age-related macular degeneration, cataract, dry eye, glaucoma, refractive error, and thyroid eye disease. (Image credit: Adobe Stock/Halfpoint)

Prevent Blindness has declared April as Women’s Eye Health and Safety Month. According to the National Eye Institute, 2 out of every 3 people living with blindness or visual impairments are women. Early detection and treatment can lessen the effects of vision loss from eye disease, and Prevent Blindness offers a variety of expert-reviewed free eye health resources including eye safety topics such as contact lenses, cosmetics, and ultraviolet (UV) protection.

Pregnancy can bring an increase in hormones that may cause vision changes. In most cases, though, these are temporary eye conditions that will return to normal postpartum. Those with pre-existing eye conditions, such as diabetes, high blood pressure, and glaucoma, should inform their eye doctor of their pregnancy to help monitor their health. Premenopausal and menopausal women may also experience vision changes.

Dry eye in particular affects premenopausal women at double the rate, according to the American Academy of Ophthalmology (AAO). The AAO also says that women are more at risk of autoimmune diseases compared to men, many of which affect vision, such as lupus and Sjögren’s syndrome.

As part of the Prevent Blindness Focus on Eye Health Expert Series, Janine Austin Clayton, MD, FARVO, associate director for Research on Women’s Health and director of the Office of Research on Women’s Health at the National Institutes of Health (NIH),shares her thoughts on a variety of women’s eye health issues including equitable access to eyecare. Clayton addresses the impact of vision loss on mental health and more in the new “Women’s Eye Health and Safety” episode.

Two-thirds of the 45 million contact lens wearers in the United States are women, according to the Centers for Disease Control and Prevention (CDC). Prevent Blindness reminds everyone that a prescription from a qualified eyecare professional is required to legally purchase contact lenses in the US, and to always wear contact lenses under the supervision of an eye doctor.

“Women lead incredibly busy and diverse lives- from running companies to running households. It is critical for women to take care of their own health needs, including eye health, to ensure they can be there for others,” said Kira Baldonado, vice president of Public Health and Policy at Prevent Blindness. “We encourage women to be a model for good health by making their eyecare a priority today to ensure healthy vision for years to come.”

For those in need of financial assistance for eyecare, Prevent Blindness has a listing in English and Spanish of available programs at: preventblindness.org/vision-care-financial-assistance-information/

Related Videos
Nazlee Zebardast, MD, MSc, overviews her ARVO 2024 presentations on glaucoma and polygenic risk scores
William Reindel, OD
Edmund Tsui, MD, details what insights swept-source anterior segment OCT images may give to determining eye inflammation
Michael Chaglasian, OD, details success of new OCT device at the ARVO 2024 meeting
Emily Chew, MD, outlines her lecture that landed her the Proctor Award at ARVO 2024
Deborah Ferrington details a session on mitochondrial maintenance and retinal health in patients with AMD at ARVO 2024
Andrew Pucker, OD, PhD
© 2024 MJH Life Sciences

All rights reserved.